Opaleye Management Inc. Savara Inc Transaction History
Opaleye Management Inc.
- $390 Million
- Q2 2024
A detailed history of Opaleye Management Inc. transactions in Savara Inc stock. As of the latest transaction made, Opaleye Management Inc. holds 714,960 shares of SVRA stock, worth $3.16 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
714,960
Previous 855,000
16.38%
Holding current value
$3.16 Million
Previous $4.26 Million
32.32%
% of portfolio
0.74%
Previous 1.04%
Shares
2 transactions
Others Institutions Holding SVRA
# of Institutions
145Shares Held
147MCall Options Held
280KPut Options Held
798K-
Nea Management Company, LLC Timonium, MD24.5MShares$108 Million9.31% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$64.4 Million12.01% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$54.6 Million7.46% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.16MShares$36.1 Million1.94% of portfolio
-
Black Rock Inc. New York, NY8.03MShares$35.5 Million0.0% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $504M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.